Itraconazole Therapy for Primary Cutaneous Aspergillosis in Patients with AIDS

Cutaneous aspergillosis occurs infrequently among HIV-infected patients; previous reports describe a total of seven patients with primary cutaneous aspergillosis [1-5]. Thus far, however, the risk factors, expected outcome, and therapeutic approach have not been defined for HIV-infected patients with primary cutaneous aspergillosis. We describe tow cases of primary cutaneous aspergillosis in patients with AIDS who were treated with itraconazole, and we present our approach to the diagnosis and management of cutaneous aspergillosis.